The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma

Objective Limited studies have reported the impact of drug-eluting bead transarterial chemoembolization (DEB-TACE) on hepatic fibrosis in hepatocellular carcinoma (HCC). This study evaluated multiple hepatic fibrosis indicators, aiming to comprehensively compare the influence of DEB-TACE and convent...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hao Li, Chao Liang, Donglin Kuang, Guohao Huang, Mengfan Zhang, Pengfei Chen, Qingzhu Zheng, Wenze Xu, Jianzhuang Ren, Xinwei Han, Xuhua Duan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis Group 2023-12-01
Saila:	Cancer Biology & Therapy
Gaiak:	hepatocellular carcinoma drug-eluting bead transarterial chemoembolization conventional transarterial chemoembolization hepatic fibrosis safety
Sarrera elektronikoa:	http://dx.doi.org/10.1080/15384047.2023.2166335
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!